These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

588 related articles for article (PubMed ID: 22010913)

  • 1. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis.
    Blanc FX; Sok T; Laureillard D; Borand L; Rekacewicz C; Nerrienet E; Madec Y; Marcy O; Chan S; Prak N; Kim C; Lak KK; Hak C; Dim B; Sin CI; Sun S; Guillard B; Sar B; Vong S; Fernandez M; Fox L; Delfraissy JF; Goldfeld AE;
    N Engl J Med; 2011 Oct; 365(16):1471-81. PubMed ID: 22010913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of antiretroviral therapy for HIV-1 infection and tuberculosis.
    Havlir DV; Kendall MA; Ive P; Kumwenda J; Swindells S; Qasba SS; Luetkemeyer AF; Hogg E; Rooney JF; Wu X; Hosseinipour MC; Lalloo U; Veloso VG; Some FF; Kumarasamy N; Padayatchi N; Santos BR; Reid S; Hakim J; Mohapi L; Mugyenyi P; Sanchez J; Lama JR; Pape JW; Sanchez A; Asmelash A; Moko E; Sawe F; Andersen J; Sanne I;
    N Engl J Med; 2011 Oct; 365(16):1482-91. PubMed ID: 22010914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of antiretroviral therapy with tuberculosis treatment.
    Abdool Karim SS; Naidoo K; Grobler A; Padayatchi N; Baxter C; Gray AL; Gengiah T; Gengiah S; Naidoo A; Jithoo N; Nair G; El-Sadr WM; Friedland G; Abdool Karim Q
    N Engl J Med; 2011 Oct; 365(16):1492-501. PubMed ID: 22010915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti.
    Severe P; Juste MA; Ambroise A; Eliacin L; Marchand C; Apollon S; Edwards A; Bang H; Nicotera J; Godfrey C; Gulick RM; Johnson WD; Pape JW; Fitzgerald DW
    N Engl J Med; 2010 Jul; 363(3):257-65. PubMed ID: 20647201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
    ; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
    N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Timing of initiation of antiretroviral drugs during tuberculosis therapy.
    Abdool Karim SS; Naidoo K; Grobler A; Padayatchi N; Baxter C; Gray A; Gengiah T; Nair G; Bamber S; Singh A; Khan M; Pienaar J; El-Sadr W; Friedland G; Abdool Karim Q
    N Engl J Med; 2010 Feb; 362(8):697-706. PubMed ID: 20181971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic or Test-Guided Treatment for Tuberculosis in HIV-Infected Adults.
    Blanc FX; Badje AD; Bonnet M; Gabillard D; Messou E; Muzoora C; Samreth S; Nguyen BD; Borand L; Domergue A; Rapoud D; Natukunda N; Thai S; Juchet S; Eholié SP; Lawn SD; Domoua SK; Anglaret X; Laureillard D;
    N Engl J Med; 2020 Jun; 382(25):2397-2410. PubMed ID: 32558469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initiation of Antiretroviral Therapy in Early Asymptomatic HIV Infection.
    ; Lundgren JD; Babiker AG; Gordin F; Emery S; Grund B; Sharma S; Avihingsanon A; Cooper DA; Fätkenheuer G; Llibre JM; Molina JM; Munderi P; Schechter M; Wood R; Klingman KL; Collins S; Lane HC; Phillips AN; Neaton JD
    N Engl J Med; 2015 Aug; 373(9):795-807. PubMed ID: 26192873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD4+ count-guided interruption of antiretroviral treatment.
    ; El-Sadr WM; Lundgren J; Neaton JD; Gordin F; Abrams D; Arduino RC; Babiker A; Burman W; Clumeck N; Cohen CJ; Cohn D; Cooper D; Darbyshire J; Emery S; Fätkenheuer G; Gazzard B; Grund B; Hoy J; Klingman K; Losso M; Markowitz N; Neuhaus J; Phillips A; Rappoport C
    N Engl J Med; 2006 Nov; 355(22):2283-96. PubMed ID: 17135583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prednisone for the Prevention of Paradoxical Tuberculosis-Associated IRIS.
    Meintjes G; Stek C; Blumenthal L; Thienemann F; Schutz C; Buyze J; Ravinetto R; van Loen H; Nair A; Jackson A; Colebunders R; Maartens G; Wilkinson RJ; Lynen L;
    N Engl J Med; 2018 Nov; 379(20):1915-1925. PubMed ID: 30428290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced CD4+ T-cell recovery with earlier HIV-1 antiretroviral therapy.
    Le T; Wright EJ; Smith DM; He W; Catano G; Okulicz JF; Young JA; Clark RA; Richman DD; Little SJ; Ahuja SK
    N Engl J Med; 2013 Jan; 368(3):218-30. PubMed ID: 23323898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial.
    Naidoo K; Yende-Zuma N; Padayatchi N; Naidoo K; Jithoo N; Nair G; Bamber S; Gengiah S; El-Sadr WM; Friedland G; Abdool Karim S
    Ann Intern Med; 2012 Sep; 157(5):313-24. PubMed ID: 22944873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nevirapine versus efavirenz for patients co-infected with HIV and tuberculosis: a randomised non-inferiority trial.
    Bonnet M; Bhatt N; Baudin E; Silva C; Michon C; Taburet AM; Ciaffi L; Sobry A; Bastos R; Nunes E; Rouzioux C; Jani I; Calmy A;
    Lancet Infect Dis; 2013 Apr; 13(4):303-12. PubMed ID: 23433590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time to initiate antiretroviral therapy between 4 weeks and 12 weeks of tuberculosis treatment in HIV-infected patients: results from the TIME study.
    Manosuthi W; Mankatitham W; Lueangniyomkul A; Thongyen S; Likanonsakul S; Suwanvattana P; Thawornwan U; Suntisuklappon B; Nilkamhang S; Sungkanuparph S;
    J Acquir Immune Defic Syndr; 2012 Aug; 60(4):377-83. PubMed ID: 22592586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.
    Hakim J; Musiime V; Szubert AJ; Mallewa J; Siika A; Agutu C; Walker S; Pett SL; Bwakura-Dangarembizi M; Lugemwa A; Kaunda S; Karoney M; Musoro G; Kabahenda S; Nathoo K; Maitland K; Griffiths A; Thomason MJ; Kityo C; Mugyenyi P; Prendergast AJ; Walker AS; Gibb DM;
    N Engl J Med; 2017 Jul; 377(3):233-245. PubMed ID: 28723333
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nevirapine- versus Efavirenz-based antiretroviral therapy regimens in antiretroviral-naive patients with HIV and Tuberculosis infections in India: a multi-centre study.
    Sinha S; Gupta K; Tripathy S; Dhooria S; Ranjan S; Pandey RM
    BMC Infect Dis; 2017 Dec; 17(1):761. PubMed ID: 29228918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-course antiretroviral therapy in primary HIV infection.
    ; Fidler S; Porter K; Ewings F; Frater J; Ramjee G; Cooper D; Rees H; Fisher M; Schechter M; Kaleebu P; Tambussi G; Kinloch S; Miro JM; Kelleher A; McClure M; Kaye S; Gabriel M; Phillips R; Weber J; Babiker A
    N Engl J Med; 2013 Jan; 368(3):207-17. PubMed ID: 23323897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integration and task shifting for TB/HIV care and treatment in highly resource-scarce settings: one size may not fit all.
    Van Rie A; Patel MR; Nana M; Vanden Driessche K; Tabala M; Yotebieng M; Behets F
    J Acquir Immune Defic Syndr; 2014 Mar; 65(3):e110-7. PubMed ID: 24091692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of antiretroviral therapy after diagnosis of cryptococcal meningitis.
    Boulware DR; Meya DB; Muzoora C; Rolfes MA; Huppler Hullsiek K; Musubire A; Taseera K; Nabeta HW; Schutz C; Williams DA; Rajasingham R; Rhein J; Thienemann F; Lo MW; Nielsen K; Bergemann TL; Kambugu A; Manabe YC; Janoff EN; Bohjanen PR; Meintjes G;
    N Engl J Med; 2014 Jun; 370(26):2487-98. PubMed ID: 24963568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.
    O'Connor J; Vjecha MJ; Phillips AN; Angus B; Cooper D; Grinsztejn B; Lopardo G; Das S; Wood R; Wilkin A; Klinker H; Kantipong P; Klingman KL; Jilich D; Herieka E; Denning E; Abubakar I; Gordin F; Lundgren JD;
    Lancet HIV; 2017 Mar; 4(3):e105-e112. PubMed ID: 28063815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.